Monday, May 4, 2020

Severe Sepsis and Septic Shock: Using SvO2 and ScvO2 to Guide Resuscitation

You've heard all these fancy terms, mixed venous blood gas, ScvO2, SvO2, thrown around the ICU all the time. Regardless of whether you're a nurse, respiratory therapist, medical student, resident, or even a fellow, these terms may sometimes be quite confusing as everyone talks about them like, "duh, you're supposed to know this".

You're here because you don't know this. Or perhaps you don't know that you don't know this. Or perhaps you need a refresher course. I am not going to get into the deep dive complexities of venous oxygen levels as that could be a complete chapter in a textbook but feel free to ask questions below and either I or our community will try to answer the questions. 

SvO2: 
- venous oxygen saturation 
- taken from a Swan Ganz catheter. without a PA catheter, you can't measure this 
- also called a mixed venous oxygen saturation. 
- this is a combination of venous oxygen from both the SVC and IVC

ScvO2
- stands for central venous oxygen saturation
- taken from a central line that terminates in the SVC or right atrium. Could be an internal jugular, subclavian, or axillary line.
- it's easy to confuse the two because the PA is more "central" but think about it as getting this value from the "central line"

Correlation
ScvO2 is generally 5-6% higher (sometimes more) as this blood comes from the brain and upper extremities which generally consume less O2 than the organs and lower extremities. This is more pronounced in shock states. 

I'll dig deeper into this in the near future. The article where these images were taken from is FREE! A hat tip to the authors. 

-EJ

Rivers EP, McIntyre L, Morro DC, Rivers KK. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ. 2005;173(9):1054‐1065. doi:10.1503/cmaj.050632

Link to Website with Article

Link to FULL FREE Article



Link to Reinhart Paper


ABIM Board Certification Exam: How I passed my critical care medicine boards

Back in December 2017, I found out that I had passed my ABIM board certification exam for critical care medicine. I created this video on youtube for those who are interested in learning about the methodologies I pursued to be able to pass this challenging exam. Needless to say, it was the most challenging board exam I have taken. Below is the link to the YouTube video. Thanks for following along.

-EJ

Link to Video on YouTube


ABIM Board Certification Exam: How I Passed my Internal Medicine Boards

Several years ago, I took and passed my ABIM Board Certification exam for internal medicine. I made this video for YouTube when I was a younger whipper snapper and it has proven to have been quite helpful for some. In this video, I go over the different methods which I used to study for and ultimately, pass the exam. 

You can watch the video here or click the link at the bottom to watch it directly on youtube where you can have greater control of the video regarding speed and other parameters. Thanks for following along! 

Link to video on youtube

-EJ




Sunday, May 3, 2020

Resuscitation and Fluid Responsiveness and Mean Arterial Pressure

We take care of sick patients. In doing so, we have various tools in our disposal including the physical exam, history, and hemodynamic parameters. We check the blood pressure on our patients and depending on that number, we do things for them (hopefully not to them). 
We place the blood pressure cuff on their extremity, hopefully the right size, and cycle it. We have learned about the limitations of the oscillometric devices as I have covered that extensively and we have learned to trust the mean arterial pressure (MAP). 

We all learned that the equation for MAP is:
MAP= [(2 x diastolic)+systolic]/3
We also learned that we should target a MAP of 65 based on the surviving sepsis guidelines and I generally agree with this. Sometimes I target a higher MAP, sometimes a lower MAP. Every patient is needs personalized care in my book. 

Here's the other equation that we should know but don't. 
MAP= (CO x SVR) + CVP
- CO= cardiac output, also HR x SV (and don't forget that the stroke volume is affected by preload, contractility, and afterload)  
- SVR= systemic vascular resistance
- CVP= central venous pressure (tends to be zero in a spontaneously breathing patient). This value tends to be ignored for the sake of simplicity. 

We all give IV fluids to increase the MAP, because that is what we see on the monitor, but that's the missing the point. 
Fluid responsiveness is defined as an increase in stroke volume or cardiac output/cardiac index after being provided with a bolus. 

Studies have shown us that only 50% of patients who are septic actually respond to fluid resuscitation. The other 50% who we blast with fluids, well, they just get overloaded and have complications secondary to that. 

The point of this post is for us to think a bit more outside the box when we have a patient who is hypotensive. We can't just look at the blood pressure after being given a liter of fluid and call the patient fluid responsive. 

The FENICE study looked at 2213 patients and 42.7% of the time, the clinicians gave IVF without looking at any hemodynamic parameters. Even when the patient had a "negative response" to the fluid bolus, 49.4% of the time, the clinician gave an additional bolus after that! I think you can call that insanity per the Einstein definition of it. 

The clinicians were looking at primarily an increase of BP followed by urine output, decrease in HR, decrease in lactate rather than changes in CO or SV. Let's just say that we have all been guilty of this in the past but need to get better on the matter. 

Here are some examples on where that thinking can lead us astray:
If the MAP is low but their CO or SV is looking great but their SVR is on the floor, they may need earlier vasopressors and nuanced fluid challenges. In the case of cardiogenic shock, you may find that the CO is on the floor and their SVR is in the clouds, those patients may benefit from some careful peripheral vasodilators with some inotropes. That undefined patient who is hypotensive and we give a liter of fluids to indiscriminately is quite dangerous at the end of the day. People come to the hospital to be helped, in those cases, we may actually be causing harm. 

If we are going to call ourselves the best, we need to practice that way. Understanding hemodynamics are crucially important to saving lives. 

-EJ


Cecconi M, Hofer C, Teboul JL, et al. Fluid challenges in intensive care: the FENICE study: A global inception cohort study [published correction appears in Intensive Care Med. 2015 Sep;41(9):1737-8. multiple investigator names added]. Intensive Care Med. 2015;41(9):1529‐1537. doi:10.1007/s00134-015-3850-x


Saturday, May 2, 2020

Ivermectin in COVID-19: Taking another look

Ivermectin in COVID, this is the second time I cover this medication during this pandemic. 

This paper has NOT been peer reviewed. I will try to peer review it myself. Ultimately, I recommend you not trust me and read the paper for yourself. A healthy dose of skepticism is needed for peer-reviewed papers these days, much more for these non-peer reviewed. 

Observational trial with all the limitation that come with it. This is not a randomized controlled trial. At least the authors went through the trouble of propensity matching some controls to help out with the outcomes. This was also international and multicenter. I'm a fan of ivermectin as it is widely available and inexpensive (ahem, tocilizumab, remdesivir).

n=1408, 704 got the study drug
Drug: 150mcg/kg x 1 dose

Primary outcome: mortality
If on mechanical ventilation: Mortality 7.3% vs 21.3% (NNT=7.1)
Overall death rates: 1.4% vs. 8.5% (NNT=14.1)<0 .0001="" font="">

Issues: no comment on PF ratio of these patients, their underlying organ dysfunction, adverse effects of the study drug. We also don't know where in the course of the illness did they get the study drug. We also don't know if they were getting other therapies outside of them being matched in the two groups. 

The patients in the Ivermectin group seems sicker at baseline: more CAD (p=0.03), more COPD/asthma, black race (which seems to be harder hit), more immunocompromised (these are not statistically significant, but there is a trend). 

Ivermectin was associated with a higher likelihood of survival. The authors claim a shorter length of stay but this is not reported anywhere in the paper. The authors recommend an RCT, I agree. 

Credit to Dr Tim Connelly who was one of my mentors during training for sharing this paper with me. 

Link to Article